These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20381159)

  • 1. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
    Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
    Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
    Paslakis G; Luppa P; Gilles M; Kopf D; Hamann-Weber B; Lederbogen F; Deuschle M
    J Psychiatr Res; 2010 Jun; 44(8):556-60. PubMed ID: 20022345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine inhibits salivary cortisol concentrations in anorexia nervosa.
    Schüle C; Sighart C; Hennig J; Laakmann G
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1015-9. PubMed ID: 16644086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment.
    Weber-Hamann B; Blum WF; Kratzsch J; Gilles M; Heuser I; Deuschle M
    Pharmacopsychiatry; 2009 Jan; 42(1):23-8. PubMed ID: 19153943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
    Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
    Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
    Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment.
    Weber-Hamann B; Kratzsch J; Kopf D; Lederbogen F; Gilles M; Heuser I; Deuschle M
    J Psychiatr Res; 2007; 41(3-4):344-50. PubMed ID: 16497334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of mirtazapine on salivary cortisol in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
    Gronau W; Paslakis G; Lederbogen F; Weber-Hamann B; Gilles M; Schilling C; Deuschle M
    Pharmacopsychiatry; 2015 Jan; 48(1):37-9. PubMed ID: 25402815
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.
    Weber-Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Kopf D; Lederbogen F; Deuschle M
    J Clin Psychopharmacol; 2008 Oct; 28(5):581-4. PubMed ID: 18794665
    [No Abstract]   [Full Text] [Related]  

  • 18. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
    Frodl T; Scheuerecker J; Schoepf V; Linn J; Koutsouleris N; Bokde AL; Hampel H; Möller HJ; Brückmann H; Wiesmann M; Meisenzahl E
    J Clin Psychiatry; 2011 Apr; 72(4):448-57. PubMed ID: 20868630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.